Skeletal in Medical Technology
Navigation Links
Skeletal in Medical Technology
... for both delaying the time to the first on-study skeletal Related Events (SREs)(fracture, radiation to ... and prostate cancers, for the prevention of skeletal related events due to the spread of cancer to the ... of serious complications, collectively called skeletal related events (SREs). These include fracture of ...
... of G4544, an internally developed compound for skeletal diseases, offers us the opportunity to submit a ... ASCO meeting. G4544, A New Oral Drug for skeletal Diseases, Enters Clinical Trials In late 2007, ... have also shown clinical activity in a range of skeletal diseases, including bone metastasis, Paget's ...
... bone loss in breast and prostate cancers, for the prevention of skeletal related events due to the spread of cancer to the bone in multiple myeloma ... bone can result in a number of serious complications, collectively called skeletal related events (SREs). These include fracture of a bone, radiation to ...
... with subsequent morbidity and eventual death almost entirely due to skeletal complications and their treatment. Some 80% of bone metastases are ... and 60% of patients with advanced disease. Current treatments for skeletal metastases are largely palliative. They include opioid analgesics, ...
... severity ranges from the severe perinatal or infantile form, with profound skeletal hypomineralization and respiratory compromise often causing death, to a ... of ENB-0040 significantly improved survival and prevented the skeletal and dental manifestations of the disease. About Enobia Pharma Inc. ...
... genetic testing for FSHD." Its major characteristic is weakening of the skeletal muscles, beginning in the face and slowly progressing to the shoulder and ... down to the abdominal and foot-extensor muscles. In the worst cases, all skeletal muscles are lost, hearing and vision are involved, and respiratory ...
... during surgery to enable endotracheal intubation and provide total skeletal muscle relaxation when the surgery requires that patients' muscles are ... blockade, thereby enabling control of the onset and offset of skeletal muscle relaxation through the use of both drugs. Sugammadex's global Phase ...
... used by leading research institutions and pharmaceutical companies worldwide in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The Company also works with large pharmaceutical and clinical partners to design ranges of tailored molecular imaging agents ...
... over the age of 65 suffer from sarcopenia, and there are currently no FDA-approved treatment options available. This deterioration of skeletal strength can also exacerbate other age-related conditions such as osteoarthritis and osteoporosis. Additional chronic diseases that involve loss of ...
... had a low-trauma hip fracture (e.g., due to a fall from standing height or less)(1). A clinical fracture is defined as a composite endpoint of skeletal sites excluding finger, face and toe. The FDA decision is based on safety and efficacy data from the landmark Recurrent Fracture Trial, published ...
... and should be stored at controlled room temperature. In clinical trials, the most common adverse events occurring in patients were hot flushes, skeletal pain, impotence and headache. As with all LHRH agonists, triptorelin causes an initial transient increase in testosterone levels and may initiate or ...
... on Form S-1 (Registration No. 333-140672) filed on February 13, 2008. FOOTNOTES (1) SEISMIC: Safety and Effects of Implanted (Autologous) skeletal Myoblasts (MyoCell(R)) using an Injection Catheter (2) MARVEL: A Phase II/III, Double-Blind, Randomized, Placebo-Controlled ...
... to cause the various symptoms of Gaucher disease, including an enlarged liver and spleen, abnormally low levels of red blood cells and platelets and skeletal complications. In some cases there is significant impairment of the central nervous system. Gaucher disease affects an estimated 8,000 to 10,000 ...
... that pairs the targeting ability of a small molecule, bone-seeking phosphonate (EDTMP) with the therapeutic potential of radiation (samarium Sm-153). skeletal invasion by prostate, breast, multiple myeloma, and other cancers often creates an imbalance between the normal process of bone destruction and ...
... most common side effects associated with the use of FROVA are dizziness, fatigue, paresthesia, flushing, headache, dry mouth, hot or cold sensation, skeletal pain, chest pain, and dyspepsia. About Endo A wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc., Endo Pharmaceuticals is a fully ...
Applying Clinical Findings to the Practice of Medicine
... ) skeletal defects Dupuytren's contracture ( ... backgrounds of representative degenerative skeletal disorders, like debilitating conditions such as ... cartilage conditions before beginning. skeletal Deformity The third Kappa Delta Award, named ...Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
... Key efficacy outcomes include assessment of skeletal and respiratory manifestations of the disease. ... severe perinatal or infantile form, with profound skeletal hypomineralization and respiratory compromise ... improved survival and prevented the skeletal and dental manifestations of the disease. About ...... of G4544, an internally developed compound for skeletal diseases, offers us the opportunity to submit a ... ASCO meeting. G4544, A New Oral Drug for skeletal Diseases, Enters Clinical Trials In late 2007, ... have also shown clinical activity in a range of skeletal diseases, including bone metastasis, Paget's ...
... bone loss in breast and prostate cancers, for the prevention of skeletal related events due to the spread of cancer to the bone in multiple myeloma ... bone can result in a number of serious complications, collectively called skeletal related events (SREs). These include fracture of a bone, radiation to ...
Phase IV Multi-center Clinical Study of Kutai Concludes in Nanjing
... that its patented version of Cisatracurium besylate, a pre-surgical skeletal muscle relaxant marketed as Kutai in China, has successfully concluded its ... successfully on September 2, 2008. Kutai is a non-depolarizing skeletal muscle relaxant for intravenous administration. Compared to other ...... with subsequent morbidity and eventual death almost entirely due to skeletal complications and their treatment. Some 80% of bone metastases are ... and 60% of patients with advanced disease. Current treatments for skeletal metastases are largely palliative. They include opioid analgesics, ...
Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease
... severity ranges from the severe perinatal or infantile form, with profound skeletal hypomineralization and respiratory compromise often causing death, to a ... of ENB-0040 significantly improved survival and prevented the skeletal and dental manifestations of the disease. In addition to the ongoing ...... severity ranges from the severe perinatal or infantile form, with profound skeletal hypomineralization and respiratory compromise often causing death, to a ... of ENB-0040 significantly improved survival and prevented the skeletal and dental manifestations of the disease. About Enobia Pharma Inc. ...
Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
... severity ranges from the severe perinatal or infantile form, with profound skeletal hypomineralization and respiratory compromise often causing death, to a ... ENB-0040 significantly improved survival and prevented the skeletal and dental manifestations of the disease. About Enobia Pharma Inc. ...... genetic testing for FSHD." Its major characteristic is weakening of the skeletal muscles, beginning in the face and slowly progressing to the shoulder and ... down to the abdominal and foot-extensor muscles. In the worst cases, all skeletal muscles are lost, hearing and vision are involved, and respiratory ...
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
... survival, are the two key goals of anti-cancer therapy of patients with skeletal metastases." Commenting on today's further positive news with ... therapeutic based on the alpha particle emitter radium-223 and may target skeletal metastases from multiple cancer types, as well as primary bone cancers. ...... during surgery to enable endotracheal intubation and provide total skeletal muscle relaxation when the surgery requires that patients' muscles are ... blockade, thereby enabling control of the onset and offset of skeletal muscle relaxation through the use of both drugs. Sugammadex's global Phase ...
... used by leading research institutions and pharmaceutical companies worldwide in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The Company also works with large pharmaceutical and clinical partners to design ranges of tailored molecular imaging agents ...
Injection Reverses Heart-Attack Damage
... reawakened. Kuhn developed a sponge-like patch, soaked in a compound called periostin that is abundant in the developing fetal heart (and in injured skeletal muscle) but scarce in adult hearts. When the patch was placed over the site of cardiac injury in rats, it induced cardiomyocyte proliferation and ...Risks of Delaying ACL Reconstruction in Young Athletes May Be Too High, Study Shows
... disturbance with early reconstruction of a torn ACL must be balanced against the risk of further knee damage by delaying treatment until closer to skeletal maturity. Our study measured the independent risk factors for and relative risk of meniscal and chondral injuries in pediatric ACL patients," said ...BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
... of N-acetylgalactosamine 6-sulfatase (GALNS) causing excessive lysosomal storage of keratan sulfate (KS). This excessive storage causes a systemic skeletal dysplasia, short stature, and joint abnormalities, which limit mobility and endurance. Malformation of the thorax as well as macrophage dysfunction ...Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps
... organs. It occurs when cancer cells at an original site metastasize or travel to the bone. These metastases can become widespread throughout the skeletal system. Some bone metastases become painful because the tumor eats away at the bone (ostelolysis), creating holes that make the bone thin and weak. ...Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
... AT2220 on GAA activity and on glycogen levels in various cells and tissues. Additional objectives include preliminary assessments of pulmonary and skeletal muscle function. Participants who complete the study may be eligible to participate in a voluntary extension study that will further evaluate the ...US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream
... increasing blood nitrate/nitrate (NOx) in human subjects. Nitric oxide acts as a vasodilator and enables an increase in blood flow to the skeletal muscles. This is significant to 1.) increasing oxygen and nutrient delivery for cellular energy production and 2.) removing metabolic wastes such as ...Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit
... go to: http://www.prnewswire.com/mnr/ahi/35313/ Called MyoCell(R) Muscle Stem Cell Therapy, the unique transplant procedure actually uses skeletal muscle stem cells (myoblasts) from the patient's own body that are injected into the heart. This may create new functioning heart muscle. Arizona ...Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
... of MI, assessment of cardiac function in the presence and absence of SDF-1 and an assessment of the distribution and phenotype of the transplanted skeletal myoblasts in a total of seven differentiated study groups of approximately five subjects each. MRI assessments were conducted at one, four and eight ...International Team Locates Key Player in Muscle Regeneration
... A New Player in Muscle Regeneration" in the Journal of Cellular Physiology ( http://www.ncbi.nlm.nih.gov/pubmed/18546201?dopt=Abstract ). Adult skeletal muscle tissue can regenerate in response to direct injury, neurological dysfunction and genetic defects. This healing process begins with an ...... over the age of 65 suffer from sarcopenia, and there are currently no FDA-approved treatment options available. This deterioration of skeletal strength can also exacerbate other age-related conditions such as osteoarthritis and osteoporosis. Additional chronic diseases that involve loss of ...
... had a low-trauma hip fracture (e.g., due to a fall from standing height or less)(1). A clinical fracture is defined as a composite endpoint of skeletal sites excluding finger, face and toe. The FDA decision is based on safety and efficacy data from the landmark Recurrent Fracture Trial, published ...
Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
... AT2220 on GAA activity and on glycogen levels in various cells and tissues. Additional objectives include preliminary assessments of pulmonary and skeletal muscle function. Participants who complete the study may be eligible to participate in a voluntary extension study that will further evaluate the ...... and should be stored at controlled room temperature. In clinical trials, the most common adverse events occurring in patients were hot flushes, skeletal pain, impotence and headache. As with all LHRH agonists, triptorelin causes an initial transient increase in testosterone levels and may initiate or ...
... on Form S-1 (Registration No. 333-140672) filed on February 13, 2008. FOOTNOTES (1) SEISMIC: Safety and Effects of Implanted (Autologous) skeletal Myoblasts (MyoCell(R)) using an Injection Catheter (2) MARVEL: A Phase II/III, Double-Blind, Randomized, Placebo-Controlled ...
Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
... Low doses of the active ingredient in Ganite administered by intravenous or subcutaneous injections have shown clinical activity in a range of skeletal diseases, including hypercalcemia, bone metastasis (myeloma and breast cancer), Paget's disease, and osteoporosis. The initial clinical trial was a ...Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
... the clinical development program. "The active ingredient in G4544 has shown a consistently high level of clinical activity across a range of skeletal diseases," said Dr. Raymond P. Warrell, Jr., Chairman and Chief Executive Officer of Genta. "Heretofore, an inconvenient dosing schedule has ...The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem Cells Work Better
... Stem Cells Isolated from Females Regenerate skeletal Muscle More Efficiently than Male Cells ... of female stem cells led to significantly better skeletal muscle regeneration," said Dr. Huard, also the ... cells leads to a much more significant level of skeletal muscle regeneration," she said. "The male cells ...Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
... demonstrate substantial increases in skeletal muscle mass and strength." ACE-031, a ... of myostatin results in the selective increase in skeletal muscle mass and strength. In preclinical models, ACE-031 increased skeletal muscle mass and strength in disease models of ...Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in Preclinical Studies
... demonstrate substantial increases in skeletal muscle mass and strength.² ACE-031, a ... of myostatin results in the selective increase in skeletal muscle mass and strength. In preclinical models, ... and effective therapies that selectively increase skeletal muscle mass and strength. About Acceleron ...Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
... to cause the various symptoms of Gaucher disease, including an enlarged liver and spleen, abnormally low levels of red blood cells and platelets and skeletal complications. In some cases there is significant impairment of the central nervous system. Gaucher disease affects an estimated 8,000 to 10,000 ...... to cause the various symptoms of Gaucher disease, including an enlarged liver and spleen, abnormally low levels of red blood cells and platelets and skeletal complications. In some cases there is significant impairment of the central nervous system. Gaucher disease affects an estimated 8,000 to 10,000 ...
... that pairs the targeting ability of a small molecule, bone-seeking phosphonate (EDTMP) with the therapeutic potential of radiation (samarium Sm-153). skeletal invasion by prostate, breast, multiple myeloma, and other cancers often creates an imbalance between the normal process of bone destruction and ...
Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
... based on positive Phase II results. Alpharadin is a novel bone-seeking therapeutic based on the alpha particle emitter radium-223 and may target skeletal metastases from multiple cancer types, as well as primary bone cancers. Algeta is also developing other technologies for delivering alpha emitters. ...New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting
... pairs the targeting ability of a small molecule, bone-seeking phosphonate (EDTMP) with the therapeutic potential of radiation (samarium Sm-153). skeletal invasion by prostate, breast, multiple myeloma, and other cancers often creates an imbalance between the normal process of bone destruction and ...... most common side effects associated with the use of FROVA are dizziness, fatigue, paresthesia, flushing, headache, dry mouth, hot or cold sensation, skeletal pain, chest pain, and dyspepsia. About Endo A wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc., Endo Pharmaceuticals is a fully ...
Other ContentsmeltdownmutationalmutationalratchetratchetmusclemusclemusclemusclemusclemusclemusclemusclemusclemusclemutagenmyosinmyosinmyosindinucleotideOther TagsEncouraginStrokStrokStrokStrokStrokOther Tagsmodifications 2modifications 3modifications 4pumps 2updates 2medicinal 2
(Date:11/23/2009)...uggests that a common oral bacterium may exacerbat...ls et al, "Unique Lipids from a Common Human Bacte... of Enhancing Autoimmunity," appears in the Decemb...y . , Multiple sclerosis (MS), a disease where t..., affects nearly 1 in 700 people in the United Sta...
(Date:11/23/2009)...A USDOE and USDA study concluded that 50 million U... pasture could be converted from current uses to t...grass, from which biomass could be harvested for u...duction of a perennial grass monoculture from whic...nually is expected to require nitrogen fertilizer....
(Date:11/23/2009)...a biomedical engineer and cardiologist Tzung "John...ians distinguish cardiac emergencies requiring imm...th drugs and lifestyle change. , Angiograms, ima...eeding the heart, offer an inside view of the inte...en revealing deposits of a dangerous fatty substan...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Switchgrass produces biomass efficiently 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Is somatic hypersensitivity a predictor of irritable bowel syndrome 3F 52394 1Is somatic hypersensitivity a predictor of irritable bowel syndrome 3F 52394 2New discovery suggests trees evolved camouflage defense against long extinct predator 9314 1New discovery suggests trees evolved camouflage defense against long extinct predator 9314 2Vaxine Wins Line Honours With Worlds First Human Swine Flu Vaccine 52390 1Vaxine Wins Line Honours With Worlds First Human Swine Flu Vaccine 52390 2(Date:11/24/2009)...s at the University of Miami School of Medicine co...rwent liver transplants for nonalcoholic steatohep...) and found no statistically significant differenc...ASH and ETOH groups. Study findings are presented ...a journal published by Wiley-Blackwell on behalf o...
(Date:11/24/2009)...Researchers from Boston University School of Medic...gineering Department have identified a number of p...h between cancer and normal cells with almost 97 p...ave developed a new computational strategy to anal...ical pathways (molecular circuits) that are active...
(Date:11/24/2009)...ERSPRING,Md.,Nov.24/PRNewswire-USNewswire/--Partie...dareallpartoftheholidaycheer.Butthemerrimentcancha... http://www.newscom.com/cgi-bin/prnh/20090824/FDAL...miting,diarrhea,andflu-likesymptoms,whichcanstarta...sareconsumed. ,, "Thegoodnewsisthatpracticingfo...
(Date:11/24/2009)...ORK,Nov.24/PRNewswire/-- Asyear-endapproaches,man...axesthisyearandnext.Tohelpyoutakeadvantageoftheses...orTaxAnalystatThomsonReuters,highlightsthefollowin..., Healthflexiblespendingaccounts(HealthFSAs) ...ytosavetaxesbyplacingfundsintheiremployer,shealthF...
(Date:11/24/2009)...erSealsNewYorkandtheNewYorkStateFraternalOrderofPo...familiesinPortJervis,NewYork ,, PORTJERVIS,N.Y....3rd,EasterSealsNewYork,inpartnershipwiththeNewYork...ivingOutreachatEasterSealsNewYork,sChildDevelopmen...ndividualscametotheoutreachtoreceivefreeturkeys,ha...
Breaking Medicine News(10 mins):Health News:New data emerges on liver transplant survival rates 2Health News:New data emerges on liver transplant survival rates 3Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:The Right Tax Moves for Employees to Make Before Year-End 2Health News:The Right Tax Moves for Employees to Make Before Year-End 3Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2[1] New data emerges on liver transplant survival rates[1] Researchers identify proteins in lung cancer cells that may provide potential drug targets[0] FDA Consumer Health Information: Food Safety Tips for Healthy Holidays[0] The Right Tax Moves for Employees to Make Before Year-End[1] Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |